|1.||Iraz, Mustafa: 7 articles (02/2009 - 02/2003)|
|2.||Yilmaz, H Ramazan: 6 articles (04/2008 - 07/2004)|
|3.||Yildirim, Zeki: 6 articles (01/2005 - 02/2003)|
|4.||Uz, Efkan: 5 articles (01/2015 - 11/2005)|
|5.||Akyol, Omer: 5 articles (02/2009 - 02/2003)|
|6.||Sogut, Sadik: 5 articles (12/2005 - 02/2003)|
|7.||Moretti, Maurizio: 4 articles (01/2015 - 04/2007)|
|8.||Armutcu, Ferah: 4 articles (05/2005 - 06/2004)|
|9.||Kotuk, Mahir: 4 articles (01/2005 - 02/2003)|
|10.||Dal Negro, R W: 3 articles (08/2015 - 01/2008)|
|1.||Chronic Obstructive Pulmonary Disease (COPD)
03/01/2009 - "Erdosteine could be most beneficial in patients who have repeated, prolonged or severe exacerbations of COPD."
08/01/2015 - "Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial."
04/01/2010 - "to test the available evidence for the efficacy of erdosteine in adults with stable or exacerbated CB/COPD. "
12/01/2007 - "Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease."
01/01/2008 - "Aim of the present study was to investigate the anti-oxidant effects of erdosteine, a recent drug currently used in chronic obstructive pulmonary disease (COPD) for its rheological activity. "
10/01/2008 - "The mucolytic drug erdosteine (Erdotin - Galen) is licensed in the UK as treatment for up to 10 days "for the symptomatic treatment of acute exacerbations of chronic bronchitis in adults". "
09/01/1999 - "[Multicenter, controlled, double-blind study of the efficacy and tolerance of Vectrine (erdostein) versus placebo in the treatment of stabilized chronic bronchitis with hypersecretion]."
01/01/1991 - "Sixteen former smokers affected by chronic bronchitis, preselected for their mucociliary responsiveness to an inhaled beta 2-agonist, were divided into two groups (matched by number, sex, age and FEV1%) and orally treated with placebo or erdosteine (300 mg t.i.d.) for 8 days. "
01/01/1991 - "Activity of erdosteine on mucociliary transport in patients affected by chronic bronchitis."
03/01/2009 - "To review the experimental and clinical trials on erdosteine in COPD and chronic bronchitis. "
09/01/2010 - "The purpose of this study was to investigate the efficacy of α-tocopherol and erdosteine combination in the reduction in injury induced by ROS in a rat model of renal ischemia-reperfusion. "
07/01/2004 - "The aim of the present study was to determine the effects of erdosteine, a new antioxidant and anti-inflammatory agent, on lipid peroxidation, neutrophil infiltration, and antioxidant enzyme activities in a rat model of renal ischemia-reperfusion (I/R) injury. "
09/01/2010 - "Our results showed that the antioxidant pretreatment with α-tocopherol and erdosteine combination reduced lipid peroxidation of renal cellular membranes in a model of normothermic renal ischemia-reperfusion in rats. "
02/01/2009 - "The erythrocyte CAT activity was higher in erdosteine group and there was a statistically significant increase, when compared with the erdosteine plus ischemia/reperfusion group. "
02/01/2009 - "(i) Control group, (ii) ischemia/reperfusion group, (iii) ischemia/reperfusion+erdosteine group, and (iv) erdosteine group. "
04/01/2010 - "The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data."
12/01/1996 - "Erdosteine is a thiol derivative developed for the treatment of chronic obstructive bronchitis, including acute infective exacerbation of chronic bronchitis. "
01/01/2008 - "The substantial antitussive effects of erdosteine were first documented in clinical trials even though mucolytic agents are regarded as not consistently effective in ameliorating cough in patients with bronchitis, although they may be of benefit to this population in other ways. "
07/01/1993 - "Although hypertonic saline aerosol and erdosteine in patients with bronchitis, and amiloride aerosol in patients with cystic fibrosis have been shown to improve mucus clearance, their clinical utility has not been adequately studied."
11/01/1995 - "Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study)."
10/01/2004 - "Erdosteine ameliorates neurological outcome and oxidative stress due to ischemia/reperfusion injury in rabbit spinal cord."
01/01/2010 - "The aim of the present study was to investigate the effect of erdosteine on renal reperfusion injury. "
01/01/2010 - "Erdosteine in renal ischemia-reperfusion injury: an experimental study in pigs."
12/01/2005 - "The aim of this study was to investigate the protective role of erdosteine, an antioxidant, on unilateral testicular reperfusion injury in rats. "
12/01/2014 - "Erdosteine and ALA decreased ischaemia-reperfusion injury in an experimental rat ovarian torsion model; combination treatment had a greater effect than either agent alone. "
|10.||Reactive Oxygen Species (Oxygen Radicals)